SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 35 filers reported holding SINOVAC BIOTECH LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $157,000 | +68.8% | 26,662 | +70.0% | 0.04% | +90.9% |
| Q3 2016 | $93,000 | -36.3% | 15,683 | -36.4% | 0.02% | -18.5% |
| Q2 2016 | $146,000 | +73.8% | 24,650 | +86.8% | 0.03% | +125.0% |
| Q1 2016 | $84,000 | +47.4% | 13,199 | +21.3% | 0.01% | +140.0% |
| Q4 2014 | $57,000 | -86.7% | 10,881 | -87.8% | 0.01% | -86.5% |
| Q3 2014 | $429,000 | -22.3% | 89,178 | -8.9% | 0.04% | -14.0% |
| Q2 2014 | $552,000 | +78.1% | 97,837 | +127.2% | 0.04% | +115.0% |
| Q1 2014 | $310,000 | +46.9% | 43,059 | +25.0% | 0.02% | +100.0% |
| Q4 2013 | $211,000 | -32.2% | 34,458 | -33.6% | 0.01% | -28.6% |
| Q3 2013 | $311,000 | +62.0% | 51,925 | +6.2% | 0.01% | +75.0% |
| Q2 2013 | $192,000 | – | 48,914 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verity Asset Management, Inc. | 35,884 | $188,000 | 0.17% |
| Orbimed Advisors | 2,667,500 | $14,004,000 | 0.10% |
| Freedom Investment Management, Inc. | 157,295 | $826,000 | 0.08% |
| Pine River Capital Management L.P. | 1,095,041 | $5,749,000 | 0.06% |
| FIRST MANHATTAN CO. LLC. | 603,666 | $3,169,000 | 0.02% |
| FIL Ltd | 1,091,500 | $5,730,000 | 0.02% |
| Renaissance Technologies | 1,263,200 | $6,632,000 | 0.02% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 179,899 | $944,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 4,068,406 | $21,359,000 | 0.01% |
| ProShare Advisors LLC | 44,592 | $234,000 | 0.00% |